What is RegaloRx?
RegaloRx specializes in personalized solutions designed to improve patient access to medicine and reduce costs. The company leverages empathy and modern technology to offer innovative pharmacy management, market access strategies, and tailored support, simplifying healthcare processes for patients. By utilizing real-time data analytics, RegaloRx aims to optimize medication adherence and elevate overall patient outcomes, working to remove barriers to accessible healthcare.
How much funding has RegaloRx raised?
RegaloRx has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in RegaloRx
PPP
Public-Private Partnership
What's next for RegaloRx?
With a large-scale late-stage funding context, RegaloRx is poised for significant expansion and further development of its patient-centric healthcare solutions. The recent strategic investment will likely fuel advancements in their technology platform, potentially broadening their reach in pharmacy management and market access services. Future growth may involve scaling operations to serve a larger patient demographic and forging new partnerships to enhance medication affordability and accessibility.
See full RegaloRx company page
